With rise of new coronavirus variants, FDA halts authorization of Evusheld

By CNN
| January 27, 2023

The FDA has halted the emergency use authorization of Evusheld because it does not appear to protect against COVID-19 from viral variants currently circulating in the United States.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...